141 related articles for article (PubMed ID: 25194810)
1. Ubiquitin C-terminal hydrolase-L3 regulates EMT process and cancer metastasis in prostate cell lines.
Song HM; Lee JE; Kim JH
Biochem Biophys Res Commun; 2014 Sep; 452(3):722-7. PubMed ID: 25194810
[TBL] [Abstract][Full Text] [Related]
2. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.
Jang MJ; Baek SH; Kim JH
Cancer Lett; 2011 Mar; 302(2):128-35. PubMed ID: 21310527
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel.
Butterworth MB; Edinger RS; Ovaa H; Burg D; Johnson JP; Frizzell RA
J Biol Chem; 2007 Dec; 282(52):37885-93. PubMed ID: 17967898
[TBL] [Abstract][Full Text] [Related]
6. UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells.
Lee JE; Lim YH; Kim JH
Anim Cells Syst (Seoul); 2021; 25(5):312-322. PubMed ID: 34745437
[TBL] [Abstract][Full Text] [Related]
7. [UCH-L3 Expression in Epithelial Ovarian Cancer and Its Clinical Significance].
Li TT; Wang HJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):556-560. PubMed ID: 31642235
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes.
Dang LC; Melandri FD; Stein RL
Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312
[TBL] [Abstract][Full Text] [Related]
9. Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3).
Dennissen FJ; Kholod N; Hermes DJ; Kemmerling N; Steinbusch HW; Dantuma NP; van Leeuwen FW
FEBS Lett; 2011 Aug; 585(16):2568-74. PubMed ID: 21762696
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
11. Characterizing substrate selectivity of ubiquitin C-terminal hydrolase-L3 using engineered α-linked ubiquitin substrates.
Navarro MF; Carmody L; Romo-Fewell O; Lokensgard ME; Love JJ
Biochemistry; 2014 Dec; 53(51):8031-42. PubMed ID: 25369561
[TBL] [Abstract][Full Text] [Related]
12. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
13. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers.
Bett JS; Ritorto MS; Ewan R; Jaffray EG; Virdee S; Chin JW; Knebel A; Kurz T; Trost M; Tatham MH; Hay RT
Biochem J; 2015 Mar; 466(3):489-98. PubMed ID: 25489924
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
17. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
Liu CH; Tang WC; Sia P; Huang CC; Yang PM; Wu MH; Lai IL; Lee KH
Int J Med Sci; 2015; 12(1):63-71. PubMed ID: 25552920
[TBL] [Abstract][Full Text] [Related]
19. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
